Current Treatment Options in Neurology

, Volume 8, Issue 1, pp 11–19

Rebound-withdrawal headache (medication overuse headache)

  • James R. Couch

Opinion statement

Rebound-withdrawal headache (medication overuse headache) is a problem that affects 1% of the population or perhaps more. Work from many countries has shown this to be a worldwide problem. It appears that the rebound-withdrawal headache often occurs on the background of pre-existing migraine or tension headache and may assume the phenotype of chronic migraine or chronic tension-type headache. The key feature of this entity is that the patient initially uses a symptomatic treatment for headache with good result. Use of this medication may increase over time, but as the use increases to more than 10 to 15 days per month, headache frequency may also increase, reaching a point where metabolic processing of the medication and removal from the system triggers another headache. The patient then finds that as use of the medication increases, the frequency and intensity of the headaches also increases, and the overall headache worsens. Once this pattern is established, therapy requires removal of the medication in order for the rebounding process to be terminated. Preventative antimigraine medications will not work in the presence of the rebound phenomenon. Once the rebound-withdrawal headache is established, it is difficult to treat. After withdrawal of the medication, there is often a high relapse rate of using the medication again with redevelopment of the rebound-withdrawal headache. Even in patients who do not relapse to drug use, headache usually remains a major problem. Recognition and treatment of rebound headache are key factors in management of these patients. Perhaps more important in regard to this entity is recognizing its existence and preventing patients from entering a pattern of rebound withdrawal, which can be achieved by early attention to their use of analgesic narcotic or migraine-abortive medications. Overall, it is likely that this will continue to be an increasing worldwide problem in managing patients with headache.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Critchley M: Migraine: from Cappadocia to Queen Square. In Background to Migraine, vol 1. Edited by Smith R. London: Heinemann; 1967.Google Scholar
  2. 2.
    Boes CJ, Capobianco DJ: Chronic migraine and medication-overuse headache through the ages. Cephalalgia 2005, 24:378–390.CrossRefGoogle Scholar
  3. 3.
    Peters GA, Horton BT: Headache with special reference to the excessive use of ergotamine tartrate and dihydroergotamine. J Lab Clin Med 1950, 36:972.PubMedGoogle Scholar
  4. 4.
    Friedman AP, Brazil PL, Von Storch TJC: Ergotamine tolerance in patients with migraine. JAMA 1955, 157:881–884.Google Scholar
  5. 5.
    Horton BT, Peters GA: Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 1963, 41:213–220. Early, well-described series of patients showing ergotamineinduced medication overuse headache.Google Scholar
  6. 6.
    Andersson PG: Ergotamine headache. Headache 1975, 15:118–121.PubMedCrossRefGoogle Scholar
  7. 7.
    Kudrow L: Paradoxical effects of frequent analgesic use. Adv Neurol 1982, 33:335–341.PubMedGoogle Scholar
  8. 8.
    Saper JR: Chronic daily headache: a clinician’s perspective. Headache 2002, 42:538–542.PubMedCrossRefGoogle Scholar
  9. 9.
    Mathew NT, Stubits E, Nigam MP: Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982, 22:66–68. The first study to link multiple factors of chronic daily headache, including psychiatric factors.PubMedCrossRefGoogle Scholar
  10. 10.
    Diener HC, Limmroth V: Medication-overuse headache: a worldwide problem. Lancet Neurol 2004, 3:475–483. Excellent recent review of medication overuse headache.PubMedCrossRefGoogle Scholar
  11. 11.
    Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Cephalalgia 2004, 24 (Suppl 1):1–160.Google Scholar
  12. 12.
    Young WB: Clinical science: treatment of medication overuse headache and long-term outcome. Headache Currents 2004, 1:55–59.CrossRefGoogle Scholar
  13. 13.
    Katsarava Z, Diener HC, Limmroth V: Medication overuse headache. A focus on analgesics, ergot alkaloids, and triptans. Drug Safety 2001, 24:921–927.PubMedCrossRefGoogle Scholar
  14. 14.
    Rapoport A, Weeks R, Sheftell F: Analgesic rebound headache: theoretical and practical implications. In Proceedings of the Second International Headache Congress. Edited by Olesen J, Tfelt-Hansen P, Jensen K. Copenhagen: Kopenhagen; 1985:448–449.Google Scholar
  15. 15.
    Couch JR: Chronic daily headache. Curr Treat Options Neurol 2003, 5:467–479.PubMedCrossRefGoogle Scholar
  16. 16.
    Micieli G, Manzoni GC, Granella F, et al.: Clinical and epidemiological observations on drug abuse in headache patients. In Drug-Induced Headache. Edited by Diener HD, Wilkinson M. Berlin: Springer Verlag; 1988:20–28.Google Scholar
  17. 17.
    Silberstein SD, Schulman EA, Hopkins MM: Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990, 30:334–339.PubMedCrossRefGoogle Scholar
  18. 18.
    Lance F, Parkes C, Wilkinson M: Does analgesic abuse cause headache de novo? Headache 1988, 38:61–62.CrossRefGoogle Scholar
  19. 19.
    Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003, 43:179–190.PubMedCrossRefGoogle Scholar
  20. 20.
    Zwart JA, Dyb G, Hagen K, et al.: Analgesic use: a predictor of chronic pain and medication overuse headache. The Head-HUNT Study. Neurology 2003, 61:160–164.PubMedGoogle Scholar
  21. 21.
    Srikiatkhachorn A: Chronic daily headache: a scientist’s perspective. Headache 2002, 42:532–537.PubMedCrossRefGoogle Scholar
  22. 22.
    Suhr B, Evers S, Bauer B, et al.: Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999, 19:45–49.CrossRefGoogle Scholar
  23. 23.
    Rapoport AM: Analgesic rebound headache. Headache 1988, 28:662–665.PubMedCrossRefGoogle Scholar
  24. 24.
    Warner JS: Prolonged recovery from rebound headaches. Headache 2001, 41:817–822.PubMedCrossRefGoogle Scholar
  25. 25.
    Holroyd KA, O’Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress-management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208–2215.PubMedCrossRefGoogle Scholar
  26. 26.
    Couch JR: Evaluation of amitriptyline in the prophylaxis of migraine headache. Arch Neurol 1979, 36:695–699.PubMedGoogle Scholar
  27. 27.
    Schinider P, Aull S, Baumgartner C, et al.: Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 1996, 16:481–485.CrossRefGoogle Scholar
  28. 28.
    Mathew NT, Kurman R, Perez F: Drug induced refractory headache--clinical features and management. Headache 1990, 30:634–638.PubMedCrossRefGoogle Scholar
  29. 29.
    Krymchantowski AV, Barbosa JS: Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000, 20:107–113.PubMedCrossRefGoogle Scholar
  30. 30.
    Jauslin P, Goadsby PJ, Lance JW: The hospital management of severe migrainous headache. Headache 1991, 31:658–660.PubMedCrossRefGoogle Scholar
  31. 31.
    Freitag FG: Preventative treatment for migraine and tension-type headaches. Do drugs having effects on muscle spasm and tone have a role? CNS Drugs 2003, 17:373–381.PubMedCrossRefGoogle Scholar
  32. 32.
    Katsarava Z, Limmroth V, Finde M, et al.: Rate and predictors for relapses in medication overuse headache: a one year prospective study. Neurology 2003, 60:1682–1683. Recent well-done study of factors of medication overuse headache.PubMedGoogle Scholar
  33. 33.
    Baumgartner C, Wessely P, Bingöl C, et al.: Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989, 29:510–514.PubMedCrossRefGoogle Scholar
  34. 34.
    Bigal ME, Rapoport AM, Sheftell FD, et al.: Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Cephalalgia 2004, 24:483–490.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  • James R. Couch
    • 1
  1. 1.Department of NeurologyOklahoma University Health Sciences CenterOklahoma CityUSA

Personalised recommendations